Valuation: Abbott Laboratories

Market Cap 19TCr 16TCr 15TCr 14TCr 26TCr 17,66800Cr 26TCr 1,77300Cr 69TCr 8,81100Cr 70TCr 68TCr 29,06000Cr P/E 2026 *
30.7x
P/E 2027 * 23.7x
Enterprise Value 21TCr 18TCr 17TCr 16TCr 29TCr 19,97100Cr 30TCr 2,00500Cr 79TCr 9,95900Cr 79TCr 77TCr 32,84900Cr EV / Sales 2026 *
4.17x
EV / Sales 2027 * 3.78x
Free-Float
86.16%
Yield 2026 *
2.41%
Yield 2027 * 2.56%
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 19TCr
-0.89%-1.19%-4.23%+2.15% 11TCr
-1.13%-4.66%+3.76%+64.41% 6TCr
+2.63%+4.85%+48.14%+59.49% 5.39TCr
-0.16%+2.21%-4.97%-37.22% 4.69TCr
+1.70%+1.27% - - 3.42TCr
-0.38%+15.93%+13.80%-27.89% 3.29TCr
-0.49%+2.34%+44.67%-8.05% 2.45TCr
+0.11%+1.07%+1.92%+3.01% 2.27TCr
+0.50%+3.29%-9.38%+5.02% 2.17TCr
Average +0.18%+5.19%+11.71%+7.62% 4.53TCr
Weighted average by Cap. +0.02%+4.29%+9.39%+12.38%

Financials

2026 *2027 *
Net sales 5.03TCr 4.37TCr 4.08TCr 3.75TCr 7.07TCr 4,79500Cr 7.19TCr 48TCr 19TCr 2,39100Cr 19TCr 18TCr 7,88700Cr 5.46TCr 4.75TCr 4.43TCr 4.07TCr 7.68TCr 5,20900Cr 7.81TCr 52TCr 20TCr 2,59800Cr 21TCr 20TCr 8,56800Cr
Net income 625.49Cr 543.61Cr 507.52Cr 465.91Cr 878.51Cr 60TCr 893.82Cr 5.98TCr 2.34TCr 30TCr 2.35TCr 2.3TCr 98TCr 792.32Cr 688.61Cr 642.89Cr 590.19Cr 1.11TCr 76TCr 1.13TCr 7.58TCr 2.97TCr 38TCr 2.98TCr 2.91TCr 1,24200Cr
Net Debt 2.42TCr 2.1TCr 1.96TCr 1.8TCr 3.39TCr 2,30300Cr 3.45TCr 23TCr 9.06TCr 1,14900Cr 9.08TCr 8.88TCr 3,78900Cr 2.14TCr 1.86TCr 1.74TCr 1.6TCr 3.01TCr 2,04100Cr 3.06TCr 20TCr 8.02TCr 1,01800Cr 8.04TCr 7.87TCr 3,35800Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
BBB